AMRX
NASDAQ · Pharmaceuticals
Amneal Pharmaceuticals Inc
$13.20
-0.52 (-3.79%)
Performance
1D
—
1W
—
1M
—
3M
-9.09%
6M
+14.98%
1Y
+78.14%
YTD
+4.27%
Open$13.62
Previous Close$13.72
Day High$13.81
Day Low$13.12
52W High$15.42
52W Low$7.02
Volume—
Avg Volume1.59M
Market Cap4.21B
P/E Ratio58.44
EPS$0.22
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$13.39
Below
SMA 200
$10.30
Above
RSI (14)
57.4
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
11 analysts
Price Target
+775.3% upside
Current
$13.20
$13.20
Target
$115.54
$115.54
$65.43
$115.54 avg
$156.42
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.96B | 2.67B | 607.96M |
| Net Income | 70.75M | 57.41M | 209.30M |
| Profit Margin | 2.4% | 2.3% | 34.4% |
| EBITDA | 585.59M | 501.54M | 317.16M |
| Free Cash Flow | — | — | 187.04M |
| Rev Growth | +10.9% | +10.9% | -4.4% |
| Debt/Equity | 136.58 | 136.58 | 0.09 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |